Top Journalists
>
Lucy Hicks

Lucy Hicks

Journalist at Medscape

Contact this person
Email address
l*****@*******.netGet email address
Influence score
63
Phone
(XXX) XXX-XXXXGet mobile number
Location
United States
Languages
  • English
Covering topics
  • Health & Medicine

View more media outlets and journalists by signing up to AI PR

View latest data and reach out all from one place
Sign up to AI PR Toolkit

Recent Articles

medscape.com

Calcium Deposition Can Increase Osteoarthritis Risk

A new analysis suggests that chondrocalcinosis is a cause, rather than just a consequence, of knee osteoarthritis.
medscape.com

New Lyme Blood Test Bests Standard Diagnostics in Detecting Early D...

New Lyme Blood Test Bests Standard Diagnostics in Detecting Early Disease
medscape.com

FDA Approves First Vagus Nerve Stimulation Device for Rheumatoid Ar...

FDA Approves First Vagus Nerve Stimulation Device for Rheumatoid Arthritis
medscape.com

HTO May Slow Knee OA Progression in Bowlegged Patients

Patients who underwent medial opening wedge high tibial osteotomy had less structural joint damage and improved outcomes at 2 years compared to those who received nonsurgical management only.
medscape.com

NIH Launches First Agency-Wide Plan for Autoimmune Disease Research

The 5-year strategy aims to accelerate diagnosis, prevention, and treatment for the millions living with autoimmune diseases in the US.
medscape.com

GLP-1s May Ease Symptom Burden in Patients With Fibromyalgia

Fibromyalgia patients taking GLP-1s have lower rates of opioid use, pain, fatigue, and malaise in a real-world patient data analysis.
medscape.com

EULAR Updates Recommendations for Managing RA

EULAR now recommends moving directly to biologic or targeted synthetic disease-modifying antirheumatic drugs if the initial methotrexate therapy fails.
medscape.com

EULAR, ERS Issue First Guideline for Managing CTD-ILD

The guidelines include disease-specific recommendations on screening, monitoring disease progression, and treatment options for ILD.
medscape.com

Vasodilators Show Severity-Dependent Effects in SSc-ILD

Different vasoactive vasodilating drugs were associated with protective effects depending on patients' vasculopathy, but exposure to these drugs did not affect overall survival.
medscape.com

Vasodilators Show Severity-Dependent Effects in SSc-ILD

Vasodilators Show Severity-Dependent Effects in SSc-ILD
medscape.com

Upadacitinib Outperforms Mycophenolate in SSc-ILD Treatment

Patients treated with upadacitinib have lower rates of lung function decline with no significant adverse events.